Question special
Featured Expert

First, I highly estimate and applaud the information provided by the rigorously conducted AKIKI trial.
Continuous RRT was applied in only 30% of the AKIKI patients. It was not specified which AKIKI patients received continuous RRT, what mode was used, and whether continuous RRT was provided at an earlier or later stage of the study. Continuous RRT has not been shown to improve mortality or to ward off dialysis dependency but may be beneficial for patients with severe fluid-overload or unstable cardiogenic/septic shock.I saw that in the supplementary material (provided by the NEJM ), we have the PHRC in french but even there you are not very clear about this very important issue.
Many thanks for clarifying this issue.
Warm regards,
Patrick Honore